Some previous reports showed that the administration of anti-human SOD1 antibody improved disease symptoms, prolonged their lifespan, and reduced the aggregation of misfolded SOD1 protein and motor neuron degeneration in mSOD1 mice (37). Here, SOD1 is linked to Motor neuron atrophy.